Market Cap
$2.8B
NEOG
NEOGEN CORP
$12.15 ▼ -0.74%
Prev close $12.24Market cap$2.8B
ConsensusBuy
12-mo target$14.00 (+15.2%)
▲ Bullish
Analyst conviction 7/10
19 New Institutional Positions17 Institutional Exits Biotech & Drug Discovery
Snapshot
The big-picture read on NEOG right now — valuation, ownership and activity at a glance.
Cap Size
Mid Cap
Analyst Consensus
Strong Buy (73%)
Inst. Holders
50 funds
Inst. Value
$1.6B
Inst. Activity
19 buys / 17 sells
Insider Activity
$5.1K buy / $0.00 sell
Insider Net $
$5.1K
Social Sentiment
50° Neutral
SEC Reports
5
Price chart 30d +4.4%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 6, 2026 earnings_calendar
NEOG Q1 2027 Earnings Scheduled — 2026-10-06
Oct 1, 2026 Insider
BOREL JAMES C was granted 9,804 shares
Director @ $12.24 ($120.0K)
Oct 1, 2026 Insider
CAPELLO JEFFREY D was granted 9,804 shares
Director @ $12.24 ($120.0K)
Oct 1, 2026 Insider
Aug 21, 2026 SEC BOREL JAMES C was granted 20,558 shares
Director
Neogen Corporation filed additional definitive proxy soliciting materials (DEFA14A) on August 21, 2026. This follows the
DEFA14A — Impact 2/10
Director Thierry Bernard resigned from Neogen's board on August 3, 2026. The filing provides no reason, no replacement,
8-K — Impact 2/10
Neogen reported Q4 FY2026 adjusted EPS of $0.09, sharply beating the $0.03 consensus, but revenue was essentially flat a
8-K — Impact 6/10
Jun 30, 2026 Inst.
Neuberger Berman Group LLC — DOUBLED
16,570,795 shares ($149.0M)
Analyst ratings buy % +14.1%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
73% rate it Buy or better · 11 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 30, 2026 | Guggenheim | MAINTAIN | Buy | 52% |
| Aug 26, 2026 | Piper Sandler | UPGRADE | Overweight | 54% |
| Aug 3, 2026 | Piper Sandler | REITERATE | Neutral | 54% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 3 | 5 | 3 | 0 | 0 | 73% | |
| Aug 1, 2026 | 3 | 4 | 4 | 0 | 0 | 64% | |
| Jul 1, 2026 | 3 | 4 | 4 | 0 | 0 | 64% | |
| Jun 1, 2026 | 3 | 4 | 3 | 0 | 0 | 70% | |
| May 1, 2026 | 3 | 4 | 4 | 0 | 0 | 64% | |
| Apr 1, 2026 | 3 | 4 | 4 | 0 | 0 | 64% | |
| Mar 1, 2026 | 3 | 4 | 4 | 0 | 0 | 64% | |
| Feb 1, 2026 | 3 | 4 | 4 | 0 | 0 | 64% |
Price targets
Where 3 covering analysts think NEOG trades over the next 12 months.
$14.00 +15.2% upside Buy
Current$12.15 Low$14.00 Median$14.00 High$14.00 3 analysts
$14.00$14.00
Analyst rating Buy· 2.0/5 as of Oct 2, 2026
Social media sentiment
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
50°
Neutral
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
5 SEC filing reports analyzed · 0 bullish, 0 bearish, 2 mixed, 3 neutral · avg impact 3.8/10.
NEUTRALDEFA14A2/10
Neogen Corporation filed additional definitive proxy soliciting materials (DEFA14A) on August 21, 20
Aug 21, 2026
NEUTRAL8-K2/10
Director Thierry Bernard resigned from Neogen's board on August 3, 2026. The filing provides no reas
Aug 7, 2026
MIXED8-K6/10
Neogen reported Q4 FY2026 adjusted EPS of $0.09, sharply beating the $0.03 consensus, but revenue wa
Jul 30, 2026
NEUTRAL8-K3/10
Neogen Corporation disclosed it has completed multiple operational qualifications for certain Petrif
Apr 20, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 6, 2026
earnings_calendar
NEOG Q1 2027 Earnings Scheduled — 2026-10-06
Oct 1, 2026
other
NEOG SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Neogen
NEOG shares gave up as much as 7.22% on FDA action over the recalled HYCOAT equine product. The selloff came with no earnings report on the calendar u
Sep 30, 2026
short_volume
Short Volume: NEOG — 62.6% short (0.8M / 1.4M)
Short: 849,994 | Exempt: 1 | TRF Vol: 1,357,881 | Short Ratio: 62.6% | Off-exchange volume (dark pool + OTC)
Sep 28, 2026
short_volume
Short Volume: NEOG — 82.9% short (1.3M / 1.6M)
Short: 1,311,351 | Exempt: 0 | TRF Vol: 1,581,706 | Short Ratio: 82.9% | Off-exchange volume (dark pool + OTC)
Sep 23, 2026
short_volume
Short Volume: NEOG — 55.1% short (0.7M / 1.3M)
Short: 699,053 | Exempt: 220 | TRF Vol: 1,268,402 | Short Ratio: 55.1% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.05 | $0.05–$0.06 | 33.3% | +0.0% | 0↑ 1↓ | $0.2B | 3 |
| Next Q | $0.09 | $0.08–$0.10 | -6.7% | +0.0% | 0↑ 1↓ | $0.2B | 3 |
| Current FY | $0.31 | $0.28–$0.35 | -3.1% | +0.0% | 0↑ 1↓ | $0.9B | 3 |
| Next FY | $0.38 | $0.32–$0.43 | 22.6% | +0.0% | 0↑ 1↓ | $0.9B | 3 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.053 | — |
| 7d ago | $0.053 | — |
| 30d ago | $0.053 | — |
| 60d ago | $0.053 | — |
| 90d ago | $0.050 | +0.003 |
Institutional ownership
Which big funds own NEOG (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $1.6B total value (178,058,531 shares) as of 2026-Q2. Top holders: NOMURA, BlackRock,, Neuberger. Net buying activity: 19 institutions added/increased vs 17 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| NOMURA ASSET MANAGEMENT CO LTD | 0 | $0.00 | 0.0% | — |
| BlackRock, Inc. | 33,431,015 | $300.5M | 18.8% | — |
| Neuberger Berman Group LLC | 16,570,795 | $149.0M | 9.3% | DOUBLED +113.8% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 13,038,732 | $117.2M | 7.3% | — |
| DIMENSIONAL FUND ADVISORS LP | 9,828,174 | $88.4M | 5.5% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 9,655,248 | $86.8M | 5.4% | — |
| ING GROEP NV | 9,102,300 | $81.8M | 5.1% | — |
| STATE STREET CORP | 8,946,377 | $80.4M | 5.0% | — |
| Hudson Bay Capital Management LP | 6,500,000 | $58.4M | 3.6% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 5,832,899 | $52.4M | 3.3% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| Neuberger Berman Group LLC | DOUBLED | 7,751,718 | 16,570,795 | +113.8% | $149.0M |
| CIBC Bancorp USA Inc. | TRIM | 5,993,222 | 3,549,006 | -40.8% | $31.9M |
| CIBC WORLD MARKET INC. | TRIM | 5,961,600 | 3,500,500 | -41.3% | $31.5M |
| AMERIPRISE FINANCIAL INC | ADD | 2,222,776 | 3,264,965 | +46.9% | $29.4M |
| BANK OF AMERICA CORP /DE/ | TRIM | 4,640,534 | 3,145,672 | -32.2% | $28.3M |
| NOMURA HOLDINGS INC | ADD | 2,088,042 | 2,786,225 | +33.4% | $25.0M |
| VICTORY CAPITAL MANAGEMENT INC | DOUBLED | 43,789 | 2,083,287 | +4657.6% | $18.7M |
| KING LUTHER CAPITAL MANAGEMENT CORP | ADD | 1,100,678 | 1,833,203 | +66.6% | $16.5M |
| FMR LLC | TRIM | 1,905,343 | 1,165,781 | -38.8% | $10.5M |
| GOLDMAN SACHS GROUP INC | TRIM | 2,226,830 | 1,106,010 | -50.3% | $9.9M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
14 insiders, 39 transactions. Net $5.1K — $5.1K bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | BOREL JAMES C | Director | AWARD | 9,804 | $12.24 | $120.0K |
| Oct 1, 2026 | CAPELLO JEFFREY D | Director | AWARD | 9,804 | $12.24 | $120.0K |
| Oct 1, 2026 | BOREL JAMES C | Director | AWARD | 20,558 | — | — |
| Oct 1, 2026 | CAPELLO JEFFREY D | Director | AWARD | 20,558 | — | — |
| Oct 1, 2026 | Green Ronald D | Director | AWARD | 9,804 | $12.24 | $120.0K |
| Oct 1, 2026 | Green Ronald D | Director | AWARD | 20,558 | — | — |
| Oct 1, 2026 | Gupta Aashima | Director | AWARD | 9,804 | $12.24 | $120.0K |
| Oct 1, 2026 | Gupta Aashima | Director | AWARD | 20,558 | — | — |
| Oct 1, 2026 | Pelossof Avi | Director | AWARD | 9,804 | $12.24 | $120.0K |
| Oct 1, 2026 | Pelossof Avi | Director | AWARD | 20,558 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for NEOG.
Shares short
11,168,684
Settlement Sep 15, 2026
Change vs prior
+5.5%
Semi-monthly cycle
Days to cover
4.5
At avg daily volume
Of shares outstanding
≈5.1%
Estimate — not % of float
All NEOG filing & press-release reports (5)
- DEFA14A reportAug 21, 2026
- 8-K reportAug 7, 2026
- 8-K reportJul 30, 2026
- 8-K reportApr 20, 2026
- 8-K reportApr 9, 2026